Loading…
Characterization of glabridin/hydroxypropyl-β-cyclodextrin inclusion complex with robust solubility and enhanced bioactivity
•Glabridin/HP-β-CD inclusion complexes were prepared and characterized.•We deduced that glabridin was included into HP-β-CD from the narrow side.•The water solubility of glabridin was increased by 1852 times.•The biological activities of glabridin were significantly enhanced.•Provide important basis...
Saved in:
Published in: | Carbohydrate polymers 2017-03, Vol.159, p.152-160 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c365t-2ddc5c991d332631d342aaf3ac1fd7e64dbf688a7a8fa2ba4467bb218cbd4a643 |
---|---|
cites | cdi_FETCH-LOGICAL-c365t-2ddc5c991d332631d342aaf3ac1fd7e64dbf688a7a8fa2ba4467bb218cbd4a643 |
container_end_page | 160 |
container_issue | |
container_start_page | 152 |
container_title | Carbohydrate polymers |
container_volume | 159 |
creator | Wei, Yongqin Zhang, Jin Zhou, Yan Bei, Weiya Li, Yuan Yuan, Qipeng Liang, Hao |
description | •Glabridin/HP-β-CD inclusion complexes were prepared and characterized.•We deduced that glabridin was included into HP-β-CD from the narrow side.•The water solubility of glabridin was increased by 1852 times.•The biological activities of glabridin were significantly enhanced.•Provide important basis for the development of glabridin application.
Various biological activities of glabridin have been reported in literature, however, the bioavailability and clinical application was limited by its low water solubility. In this study, we developed a novel inclusion complex of glabridin and hydroxypropyl-β-cyclodextrin (HP-β-CD) that features improved solubility and bioactivity. The formation of the inclusion complex was supported by data from FT-IR, PXRD, SEM and NMR. Specifically, the NMR results indicated that the aromatic ring of glabridin was merged into and located at the narrow side the cavity of HP-β-CD. The in vitro tests showed that the formation of the inclusion complex led to 9 times increase in the DPPH radical-scavenging capacity and 20 times increase in the tyrosinase inhibitory activity compared to the free glabridin at the same concentration. Therefore, the glabridin/HP-β-CD inclusion complex adds a promising strategy for the clinical application of glabridin in the future. |
doi_str_mv | 10.1016/j.carbpol.2016.11.093 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1854615240</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0144861716313637</els_id><sourcerecordid>1854615240</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-2ddc5c991d332631d342aaf3ac1fd7e64dbf688a7a8fa2ba4467bb218cbd4a643</originalsourceid><addsrcrecordid>eNqFkM9u1DAQxi1ERbeFRwDlyCWpHTuO94TQqrRIlbjQszX-E9Yrbxxsp2yQeCkehGeqV7twZS6j0XzffJofQm8Jbggm_GbXaIhqCr5py9gQ0uA1fYFWRPTrmlDGXqIVJozVgpP-El2ltMOlOMGv0GUrMBU9Yyv0a7OFCDrb6H5CdmGswlB986CiM2682S4mhsMyxTAtvv7zu9aL9sHYQ45urNyo_ZyOJh32k7eH6ofL2yoGNadcpeBn5bzLSwWjqey4hVFbUykXSqB7KovX6GIAn-ybc79Gj59uv27u64cvd583Hx9qTXmX69YY3en1mhhKW05LYy3AQEGTwfSWM6MGLgT0IAZoFTDGe6VaIrQyDDij1-j96W555PtsU5Z7l7T1HkYb5iSJ6BgnXctwkXYnqY4hpWgHOUW3h7hIguWRvNzJM3l5JC8JkYV88b07R8xqb80_11_URfDhJLDl0Sdno0za2SMRF63O0gT3n4hnup-dKg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1854615240</pqid></control><display><type>article</type><title>Characterization of glabridin/hydroxypropyl-β-cyclodextrin inclusion complex with robust solubility and enhanced bioactivity</title><source>ScienceDirect Journals</source><creator>Wei, Yongqin ; Zhang, Jin ; Zhou, Yan ; Bei, Weiya ; Li, Yuan ; Yuan, Qipeng ; Liang, Hao</creator><creatorcontrib>Wei, Yongqin ; Zhang, Jin ; Zhou, Yan ; Bei, Weiya ; Li, Yuan ; Yuan, Qipeng ; Liang, Hao</creatorcontrib><description>•Glabridin/HP-β-CD inclusion complexes were prepared and characterized.•We deduced that glabridin was included into HP-β-CD from the narrow side.•The water solubility of glabridin was increased by 1852 times.•The biological activities of glabridin were significantly enhanced.•Provide important basis for the development of glabridin application.
Various biological activities of glabridin have been reported in literature, however, the bioavailability and clinical application was limited by its low water solubility. In this study, we developed a novel inclusion complex of glabridin and hydroxypropyl-β-cyclodextrin (HP-β-CD) that features improved solubility and bioactivity. The formation of the inclusion complex was supported by data from FT-IR, PXRD, SEM and NMR. Specifically, the NMR results indicated that the aromatic ring of glabridin was merged into and located at the narrow side the cavity of HP-β-CD. The in vitro tests showed that the formation of the inclusion complex led to 9 times increase in the DPPH radical-scavenging capacity and 20 times increase in the tyrosinase inhibitory activity compared to the free glabridin at the same concentration. Therefore, the glabridin/HP-β-CD inclusion complex adds a promising strategy for the clinical application of glabridin in the future.</description><identifier>ISSN: 0144-8617</identifier><identifier>EISSN: 1879-1344</identifier><identifier>DOI: 10.1016/j.carbpol.2016.11.093</identifier><identifier>PMID: 28038744</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Glabridin ; Hydroxypropyl-β-cyclodextrin ; Inclusion complex</subject><ispartof>Carbohydrate polymers, 2017-03, Vol.159, p.152-160</ispartof><rights>2016 Elsevier Ltd</rights><rights>Copyright © 2016 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-2ddc5c991d332631d342aaf3ac1fd7e64dbf688a7a8fa2ba4467bb218cbd4a643</citedby><cites>FETCH-LOGICAL-c365t-2ddc5c991d332631d342aaf3ac1fd7e64dbf688a7a8fa2ba4467bb218cbd4a643</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28038744$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wei, Yongqin</creatorcontrib><creatorcontrib>Zhang, Jin</creatorcontrib><creatorcontrib>Zhou, Yan</creatorcontrib><creatorcontrib>Bei, Weiya</creatorcontrib><creatorcontrib>Li, Yuan</creatorcontrib><creatorcontrib>Yuan, Qipeng</creatorcontrib><creatorcontrib>Liang, Hao</creatorcontrib><title>Characterization of glabridin/hydroxypropyl-β-cyclodextrin inclusion complex with robust solubility and enhanced bioactivity</title><title>Carbohydrate polymers</title><addtitle>Carbohydr Polym</addtitle><description>•Glabridin/HP-β-CD inclusion complexes were prepared and characterized.•We deduced that glabridin was included into HP-β-CD from the narrow side.•The water solubility of glabridin was increased by 1852 times.•The biological activities of glabridin were significantly enhanced.•Provide important basis for the development of glabridin application.
Various biological activities of glabridin have been reported in literature, however, the bioavailability and clinical application was limited by its low water solubility. In this study, we developed a novel inclusion complex of glabridin and hydroxypropyl-β-cyclodextrin (HP-β-CD) that features improved solubility and bioactivity. The formation of the inclusion complex was supported by data from FT-IR, PXRD, SEM and NMR. Specifically, the NMR results indicated that the aromatic ring of glabridin was merged into and located at the narrow side the cavity of HP-β-CD. The in vitro tests showed that the formation of the inclusion complex led to 9 times increase in the DPPH radical-scavenging capacity and 20 times increase in the tyrosinase inhibitory activity compared to the free glabridin at the same concentration. Therefore, the glabridin/HP-β-CD inclusion complex adds a promising strategy for the clinical application of glabridin in the future.</description><subject>Glabridin</subject><subject>Hydroxypropyl-β-cyclodextrin</subject><subject>Inclusion complex</subject><issn>0144-8617</issn><issn>1879-1344</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqFkM9u1DAQxi1ERbeFRwDlyCWpHTuO94TQqrRIlbjQszX-E9Yrbxxsp2yQeCkehGeqV7twZS6j0XzffJofQm8Jbggm_GbXaIhqCr5py9gQ0uA1fYFWRPTrmlDGXqIVJozVgpP-El2ltMOlOMGv0GUrMBU9Yyv0a7OFCDrb6H5CdmGswlB986CiM2682S4mhsMyxTAtvv7zu9aL9sHYQ45urNyo_ZyOJh32k7eH6ofL2yoGNadcpeBn5bzLSwWjqey4hVFbUykXSqB7KovX6GIAn-ybc79Gj59uv27u64cvd583Hx9qTXmX69YY3en1mhhKW05LYy3AQEGTwfSWM6MGLgT0IAZoFTDGe6VaIrQyDDij1-j96W555PtsU5Z7l7T1HkYb5iSJ6BgnXctwkXYnqY4hpWgHOUW3h7hIguWRvNzJM3l5JC8JkYV88b07R8xqb80_11_URfDhJLDl0Sdno0za2SMRF63O0gT3n4hnup-dKg</recordid><startdate>20170301</startdate><enddate>20170301</enddate><creator>Wei, Yongqin</creator><creator>Zhang, Jin</creator><creator>Zhou, Yan</creator><creator>Bei, Weiya</creator><creator>Li, Yuan</creator><creator>Yuan, Qipeng</creator><creator>Liang, Hao</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170301</creationdate><title>Characterization of glabridin/hydroxypropyl-β-cyclodextrin inclusion complex with robust solubility and enhanced bioactivity</title><author>Wei, Yongqin ; Zhang, Jin ; Zhou, Yan ; Bei, Weiya ; Li, Yuan ; Yuan, Qipeng ; Liang, Hao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-2ddc5c991d332631d342aaf3ac1fd7e64dbf688a7a8fa2ba4467bb218cbd4a643</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Glabridin</topic><topic>Hydroxypropyl-β-cyclodextrin</topic><topic>Inclusion complex</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wei, Yongqin</creatorcontrib><creatorcontrib>Zhang, Jin</creatorcontrib><creatorcontrib>Zhou, Yan</creatorcontrib><creatorcontrib>Bei, Weiya</creatorcontrib><creatorcontrib>Li, Yuan</creatorcontrib><creatorcontrib>Yuan, Qipeng</creatorcontrib><creatorcontrib>Liang, Hao</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Carbohydrate polymers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wei, Yongqin</au><au>Zhang, Jin</au><au>Zhou, Yan</au><au>Bei, Weiya</au><au>Li, Yuan</au><au>Yuan, Qipeng</au><au>Liang, Hao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterization of glabridin/hydroxypropyl-β-cyclodextrin inclusion complex with robust solubility and enhanced bioactivity</atitle><jtitle>Carbohydrate polymers</jtitle><addtitle>Carbohydr Polym</addtitle><date>2017-03-01</date><risdate>2017</risdate><volume>159</volume><spage>152</spage><epage>160</epage><pages>152-160</pages><issn>0144-8617</issn><eissn>1879-1344</eissn><abstract>•Glabridin/HP-β-CD inclusion complexes were prepared and characterized.•We deduced that glabridin was included into HP-β-CD from the narrow side.•The water solubility of glabridin was increased by 1852 times.•The biological activities of glabridin were significantly enhanced.•Provide important basis for the development of glabridin application.
Various biological activities of glabridin have been reported in literature, however, the bioavailability and clinical application was limited by its low water solubility. In this study, we developed a novel inclusion complex of glabridin and hydroxypropyl-β-cyclodextrin (HP-β-CD) that features improved solubility and bioactivity. The formation of the inclusion complex was supported by data from FT-IR, PXRD, SEM and NMR. Specifically, the NMR results indicated that the aromatic ring of glabridin was merged into and located at the narrow side the cavity of HP-β-CD. The in vitro tests showed that the formation of the inclusion complex led to 9 times increase in the DPPH radical-scavenging capacity and 20 times increase in the tyrosinase inhibitory activity compared to the free glabridin at the same concentration. Therefore, the glabridin/HP-β-CD inclusion complex adds a promising strategy for the clinical application of glabridin in the future.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>28038744</pmid><doi>10.1016/j.carbpol.2016.11.093</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0144-8617 |
ispartof | Carbohydrate polymers, 2017-03, Vol.159, p.152-160 |
issn | 0144-8617 1879-1344 |
language | eng |
recordid | cdi_proquest_miscellaneous_1854615240 |
source | ScienceDirect Journals |
subjects | Glabridin Hydroxypropyl-β-cyclodextrin Inclusion complex |
title | Characterization of glabridin/hydroxypropyl-β-cyclodextrin inclusion complex with robust solubility and enhanced bioactivity |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T15%3A02%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterization%20of%20glabridin/hydroxypropyl-%CE%B2-cyclodextrin%20inclusion%20complex%20with%20robust%20solubility%20and%20enhanced%20bioactivity&rft.jtitle=Carbohydrate%20polymers&rft.au=Wei,%20Yongqin&rft.date=2017-03-01&rft.volume=159&rft.spage=152&rft.epage=160&rft.pages=152-160&rft.issn=0144-8617&rft.eissn=1879-1344&rft_id=info:doi/10.1016/j.carbpol.2016.11.093&rft_dat=%3Cproquest_cross%3E1854615240%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c365t-2ddc5c991d332631d342aaf3ac1fd7e64dbf688a7a8fa2ba4467bb218cbd4a643%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1854615240&rft_id=info:pmid/28038744&rfr_iscdi=true |